Alnylam Pharmaceuticals
ALNY
#568
Rank
$40.85 B
Marketcap
$308.05
Share price
0.45%
Change (1 day)
5.97%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company